2009 annual financial data

Sarepta Therapeutics 2009 Net margin

Sarepta Therapeutics 2009 net margin with verified reported values.

Direct answer

Net margin was -143.07%.

Operating income was -15,507,000 USD and net income was -25,159,000 USD.
Operating cash flow was -8,800,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
17,585,000 USD
Operating income
-15,507,000 USD
Net income
-25,159,000 USD
Operating cash flow
-8,800,000 USD